M E D IC A 2 0 2 2

MARKET UPDATEGERMANY: DIAGNOSTICS
AND ANALYTICS
DÜSSELDORF, NOVEMBER 2022
Gregor Kemper
Project Manager
www.gtai.deThe Diagnostics and Analytics
Industry in GermanyAgenda
1. Diagnostics: market data and statistics

2. Analytics: market data and statistics
3. Current trends and developments© GTAI 2

1. DIAGNOSTICS
MARKET DATA AND STATISTICS© GTAI 3

Diagnostics sales in Germany experienced
an unprecedented growth of 120% in 2021

6.03

[EUR bn]

2.74

2020
Source: VDGH, Statista ResearchThis growth wasprimarily due toincreased reagent
sales; the market for
devices and services
decreased in size

2021
© GTAI 4

The explosive growth in 2021 was mainly
carried by infectious disease diagnostics
Reagent market segments:
Clinical Hematology
Chemistry
4%
8%

Reagents accounted
for 95% of the German
IVD market in 2021.

ImmuneChemistry
10%

Microbiology
3%
Genetic testing1%

Infectious
Immunology
74%

Source: VDGH

© GTAI 5

Genetic testing is a small segment, but thefastest growing one
Growth rate [%]

18/19
431,3

19/20

269,3

20/21

295,6

The total IVD market
without COVID-19
testing grew by 1,2%
in 2021.

120,944,6

2-0,7
Reagents total
Source: VDGHInfectious
diseases

1,1-12,2
Genetictesting

3,17-2,3
Immunochemistry© GTAI 62. ANALYTICS AND RESEARCH
MARKET DATA AND STATISTICS© GTAI 7

A return to regular, steady growth isexpected for the analytical, biological andlab technology industry
2021

2022 (estimates)

Revenue: +12.5% [EUR 10.88 bn]

Revenue: +6.9%

Export: +12.9% [EUR 6.05 bn]

Export: +7,6%

Staff: +3.7%

Staff: +5,2%Source: Spectaris© GTAI 8

Although most exports from Germany go toEU countries, China is the #1 destination

50%

The top countries of origin
for imports to Germany inthis industry field are theUSA and Japan.

of Analytics, bio and lab technology companies inGermany have plans to expand to China

Source: Spectaris© GTAI 9The market for products used in Life Science
research exhibited solid growth last year

Revenue€ 3.17 bn

Growth 2020/2021

9.7%

Employees

20,000© GTAI 10

Source: VDGH

3. CURRENT TRENDS
AND DEVELOPMENTS© GTAI 11

Germany ended its free antigen program inJune 2022
Free antigen tests for vulnerable
groups and in healthcare facilities
3€ antigen tests for people withhigh infection risk

Since COVID-19 testing was critical forrevenue growth in the past years, how is theend of free testing going to impact themarket?

Out-of-pocket for everyone else
Cource: BMG© GTAI 12

Despite the end of free antigen tests, thenumber of tests only decreased by a bit morethan half# of tests

Number of tests by weeks in Germany
2.000.000
1.800.000
1.600.000
1.400.000
1.200.0001.000.000
800.000
600.000
400.000
200.000
-2021
2022

31

Many of the COVID-19
diagnostics approvedin the EU are supplied
by international
companies.
33

Source: RKI, 25.10.2021 and 9.11.2022

35
37
Calendar Week (2021)

3941© GTAI 13

IVDR: What‘s new• Harmonized EU IVD market, enteredinto force in May• Modification from 2021 extended
deadline for some products up until
2027, depending on risk class• Only dates were changed, otherobligations apply immediately© GTAI 14
Source: Johner Institut

Current topics

Current topics

Digital labServitizationDevelopment of an international
OPC-standard to enableinteroperability between lab
equipment. The standard isscheduled to be finalized next year.

Among companies in Germany,
services are an increasingly important
addition to their analytics, biotech adlab technology products. Over two
thirds of companies generate at least
10% of their revenue with services.
© GTAI 15

Our services forinternational clients• Information about growthmarkets in Germany• Legal information• Tax information• Incentives and financing
information• Introduction to local partners• Site selection support© GTAI 16

AthenBrüssel
HelsinkiLondon

ChicagoNew York
San Francisco
TorontoWashington D.C.

Buenos Aires
Bogotá
Mexico City
Santiago de Chile
Sao PauloMadrid
MailandParis
Stockholm

BerlinBonnCasablanca
Kairo
Jerusalem
TeheranTunis
Accra
AbidjanJohannesburg
Lagos
Nairobi

AlmatyBelgradBudapest
Bukarest
Kiew

MoskauPrag
Sofia
Warschau
ZagrebBangkokBeijing
Hanoi
Hong Kong
Jakarta
Kuala Lumpur
Mumbai
ManilaNew Delhi
Seoul
ShanghaiTaipeiTokio

Dubai
Istanbul
Riad
TeheranSydney© GTAI 17

Contact Us
Germany Trade & Invest is the economic development agency of the Federal Republic of Germany. The company helps create and secure extra
employment opportunities, strengthening Germany as a business location. With more than 50 offices in Germany and abroad and its network ofpartners throughout the world, Germany Trade & Invest supports German companies setting up in foreign markets, promotes Germany as a businesslocation and assists foreign companies setting up in Germany.

Contact

Germany Trade & Invest

Gregor Kemper
T +49 (0)30 200 099-162
gregor.kemper@gtai.com

Friedrichstraße 60
10117 Berlinwww.gtai.com

SUPPORTED BY THE FEDERAL MINISTRY FOR ECONOMIC AFFAIRS AND ENERGYON THE BASIS OF A DECISION BY THE GERMAN BUNDESTAG.
© Germany Trade & Invest
All market data provided is based on the most current market information available at the time of publication.
Germany Trade & Invest accepts no liability for the actuality, accuracy, or completeness of the information provided.

© GTAI 18